Drug
Artesunate + Mefloquine
Artesunate + Mefloquine is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
25%
Ph phase_3
2
50%
Ph phase_4
1
25%
Phase Distribution
0
Early Stage
0
Mid Stage
3
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
2(50.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
1(25.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Other(1)
Detailed Status
Completed3
unknown1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 32 (50.0%)
Phase 41 (25.0%)
N/A1 (25.0%)
Trials by Status
completed375%
unknown125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
NCT03893097
unknownphase_4
Malaria Elimination Pilot Study in Military Forces in Cambodia
NCT02653898
completednot_applicable
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
NCT00493363
completedphase_3
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
NCT02974348
Clinical Trials (4)
Showing 4 of 4 trials
NCT03893097Phase 3
Evaluation of Artesunate-mefloquine as a Novel Alternative Treatment for Schistosomiasis in African Children
NCT02653898Phase 4
Malaria Elimination Pilot Study in Military Forces in Cambodia
NCT00493363Not Applicable
Clinical Investigation of In-vivo Susceptibility of P.Falciparum to Artesunate in Western Cambodia
NCT02974348Phase 3
Antimalaria Drugs Susceptibility Testing for an Effective Management of Infected Patients in Sub-Sahara Africa
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4